News About  

Role of synTQ in advancing biologics highlighted at BioProcess International Europe

04/05/2022 10:47:03
Download Text
ImagesClick Image for 300dpi jpg fileRole of synTQ in advancing biologics highlighted at BioProcess International Europe

Optimal Industrial Technologies will showcase the role of Process Analytical Technology (PAT) in enabling advanced biopharmaceutical manufacturing at BioProcess International Europe 2022 on stand 53. From 17th-20th May, visitors will be able to learn how the company’s award-winning PAT knowledge management platform, synTQ, can improve quality, lower cost and save time across all phases of bioprocessing.

BioProcess International Europe is a leading event for biopharmaceutical manufacturers. By providing a platform to discover the latest innovative scientific data, technologies and collaborations, it helps to promote next-generation targeted drug therapies and advanced therapy medicinal products.

As a leading innovator in process control and quality assurance, Optimal will demonstrate the opportunities offered by PAT for process intensification and optimisation. In particular, the company will exhibit the ways in which successful PAT implementations support digitalisation strategies in the biologics industry, providing manufacturers with a competitive edge. By relying on a real-time, interconnected and data-driven setup, companies can boost accurate decision making, improving the performance of development and production facilities.

On booth 53, attendees will be able to learn how PAT and synTQ can reduce processing and cycle times as well as costs while maximising end product quality and consistency. In addition, they will be invited to explore how key production activities can benefit from enhanced process control, complemented by real-world examples from (bio)pharmaceutical majors.

Martin Gadsby, VP at Optimal, comments: “PAT offers a key solution to futureproofing biopharmaceutical operations. Our market-leading software, synTQ, has a proven track record of helping manufacturers get the most out of their facilities and creating a competitive edge. We invite anyone looking to advance their productivity and efficiency to visit our experts on stand 53.”

Visit Optimal on stand 53 at BioProcess International Europe 2022, taking place from 17th-20th May at Messe Wien Congress Centre, Vienna, Austria:

Image Captions: Optimal will exhibit at BioProcess International Europe 2022, taking place from 17th-20th May at Messe Wien Congress Centre, Vienna, Austria.
Image Source: iStock 1309776504

About Optimal Industrial Technologies Ltd

Within the Optimal group, we have more than 30 years’ experience in the automation and optimisation of control and data management systems for the food, chemical, pharmaceutical, biotech, life science and other process industries.

The demands being placed on manufacturers in relation to getting products to market sooner, minimising development and production costs together with increasing product quality and business sustainability are ever increasing. Our primary aim is to deliver measurable improvements in all these target areas.

In addition to practical automation and system integration expertise, Optimal Industrial Technologies has also developed the world-leading PAT Knowledge Management software platform – synTQ® – which is used by over 60% of the world’s leading pharmaceutical and biotech companies, and is now being adopted by other process industries. synTQ has been a proven enabler of QbD via PAT by significantly increasing productivity and quality, while reducing waste, time to manufacture and time to market for batch and continuous processes.

The image(s) distributed with this press release may only be used to accompany this copy, and are subject to copyright. Please contact DMA Europa if you wish to license the image for further use.

Editor Contact

DMA Europa Ltd. : Dr. Chiara Civardi
Tel: +44 (0) 1905 917477 Fax:

Company Contact

Optimal Industrial Technologies Ltd : Martin Gadsby
Tel: +44 (0) 1173 742 222 Fax: +44 (0) 1454 322 240

  [ Back ]  
About the DMA Group Click to Read More